Shandong Teamgene Technology Co. Ltd. A (603151) - Total Liabilities

Latest as of June 2025: CN¥1.48 Billion CNY ≈ $216.40 Million USD

Based on the latest financial reports, Shandong Teamgene Technology Co. Ltd. A (603151) has total liabilities worth CN¥1.48 Billion CNY (≈ $216.40 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Shandong Teamgene Technology Co. Ltd. A operating cash flow efficiency to assess how effectively this company generates cash.

Shandong Teamgene Technology Co. Ltd. A - Total Liabilities Trend (2020–2024)

This chart illustrates how Shandong Teamgene Technology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Shandong Teamgene Technology Co. Ltd. A's assets to evaluate the company's liquid asset resilience ratio.

Shandong Teamgene Technology Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Shandong Teamgene Technology Co. Ltd. A ranked by their total liabilities.

Company Country Total Liabilities
Holtek Semiconductor Inc
TW:6202
Taiwan NT$1.65 Billion
Swancor Holding Co Ltd
TW:3708
Taiwan NT$6.08 Billion
Huitong Construction Group Co.Ltd.
SHG:603176
China CN¥4.71 Billion
Bukwang Pharm
KO:003000
Korea ₩132.16 Billion
GnCenergy Co Ltd
KQ:119850
Korea ₩98.17 Billion
Plastika Kritis S.A.
AT:PLAKR
Greece €65.70 Million
Marshall Boya ve Vernik Sanayi AS
IS:MRSHL
Turkey TL3.06 Billion
Wuhu Conch Profiles and Science Co Ltd
SHE:000619
China CN¥2.34 Billion

Liability Composition Analysis (2020–2024)

This chart breaks down Shandong Teamgene Technology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 603151 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.43 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.13 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.51 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shandong Teamgene Technology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shandong Teamgene Technology Co. Ltd. A (2020–2024)

The table below shows the annual total liabilities of Shandong Teamgene Technology Co. Ltd. A from 2020 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥518.56 Million
≈ $75.88 Million
+121.82%
2023-12-31 CN¥233.77 Million
≈ $34.21 Million
+43.20%
2022-12-31 CN¥163.25 Million
≈ $23.89 Million
+33.45%
2021-12-31 CN¥122.33 Million
≈ $17.90 Million
-24.43%
2020-12-31 CN¥161.87 Million
≈ $23.69 Million
--

About Shandong Teamgene Technology Co. Ltd. A

SHG:603151 China Farm Products
Market Cap
$399.84 Million
CN¥2.73 Billion CNY
Market Cap Rank
#13728 Global
#4331 in China
Share Price
CN¥15.98
Change (1 day)
+1.33%
52-Week Range
CN¥14.45 - CN¥30.77
All Time High
CN¥30.77
About

Shandong Teamgene Technology Co., Ltd. engages in the research, development, production, and sale of pig feed that focuses on animal life and animal nutrition research in China. It offers pig feed, egg and poultry premixes, meat ruminant feed, and aquatic products, as well as sales veterinary drug. The company was founded in 2007 and is based in Zibo, China.